Robinhood Markets saw its stock plunge nearly 10% on Monday, underperforming broader markets and financial sector peers, as a sharp downturn in Bitcoin and fading retail crypto trading activity sparked investor concerns over its transaction-dependent revenue streams.
From under a dollar to over three, the price of a dozen eggs tells a story of inflation, disease, and changing agriculture. We break down the real cost by decade and explore what's driving your grocery bill higher.
As Alphabet prepares to report its fourth-quarter results, investors are weighing the company's robust AI-driven growth against a stock that may have already priced in much of the good news.
The Bureau of Labor Statistics has postponed the release of January's highly anticipated employment data due to a partial federal funding lapse, marking the latest economic disruption from Washington's budget impasse.
As Alphabet prepares to report its fourth-quarter results, traders are bracing for significant stock movement. The focus is on whether strong performance in cloud and AI can justify its recent surge and sustain momentum amid heightened investor scrutiny.
Major U.S. stock indices advanced Monday, setting a positive tone for a week packed with corporate earnings reports from technology giants and other bellwethers. Investor sentiment remains cautiously optimistic as early results surpass expectations.
Disney's stock fell sharply Monday, reflecting investor unease over the financial toll of its transition from traditional cable to direct-to-consumer streaming, despite overall revenue growth.
Former Fed governor Kevin Warsh, nominated to lead the central bank, previously advised the firm issuing Tether's new U.S.-regulated stablecoin, intertwining his potential oversight role with a key player in the digital asset industry.
While many AI stocks trade at sky-high premiums, Nebius Group presents a contrasting case. Analysts project a staggering revenue surge for 2026, suggesting its current valuation might not fully reflect its growth trajectory in the competitive cloud AI space.
Palantir Technologies smashed Wall Street expectations for Q4 2025, reporting a 70% surge in revenue and issuing guidance that signals even stronger growth ahead. The data analytics giant's performance underscores its deepening traction in both government and commercial sectors.
Ed Martin, a controversial Trump appointee, has been ousted from his role leading the Justice Department's 'Weaponization Working Group' following internal clashes and scrutiny over his conduct, though he remains in a separate advisory position.
The Texas-born travel center giant Buc-ee's is renowned for massive stores and spotless restrooms. But its most disruptive industry practice might be its pay scale, which far exceeds typical convenience store wages and fuels intense competition for jobs.
President Trump urges immediate House passage of a bipartisan spending deal to end the government shutdown, facing resistance from both progressive Democrats and his own party's right flank over immigration enforcement terms.
The Trump administration is launching a strategic reserve for rare earths and critical minerals, echoing the 1970s response to the oil crisis, as global competition for tech supply chains intensifies.
Canopy Growth's shares have plummeted over 99% in five years, yet analysts warn its challenges run deeper than its stock price suggests. Despite recent U.S. regulatory changes, structural industry headwinds and the company's own track record make it a speculative play at best.
Newly filed state documents reveal the geographic breakdown of Amazon's latest workforce reduction in Washington, with T-Mobile and International Paper also submitting layoff notices affecting hundreds more employees across the state.
A severe, AI-driven shortage of memory chips is creating a windfall for storage manufacturers, with analysts predicting a multi-year upcycle as data center demand overwhelms supply.
As AMD prepares to release its fourth-quarter results, the chipmaker finds itself at a critical juncture, balancing Wall Street's anxiety over AI infrastructure costs against its aggressive push to challenge Nvidia's dominance with new data center and PC products.
TD Cowen and H.C. Wainwright have raised price targets on KalVista Pharmaceuticals, expressing confidence in its oral hereditary angioedema treatment ahead of the company's fourth-quarter financial results.
A deep dive into the software company's valuation using a discounted cash flow model suggests its shares may be trading at a significant premium to their estimated intrinsic value.
